Griseofulvin 125 mg/5mL
Griseofulvin · SUSPENSION · Actavis Pharma, Inc.
No Recall History
Plain English
Griseofulvin is a suspension containing griseofulvin at 125 mg/5mL, taken oral. Manufactured by Actavis Pharma, Inc..
Key Facts
- Brand Name
- Griseofulvin
- Generic Name
- Griseofulvin
- NDC Code (Product)
0472-0013- Manufacturer
- Actavis Pharma, Inc.
- Strength
- 125 mg/5mL
- Dosage Form
- SUSPENSION
- Route
- ORAL
- Marketing Status
- Application #
- ANDA065394
- Drug Class
- Tubulin Inhibiting Agent [EPC]
- Marketing Start
- 07/26/2007
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
drug ineffective39 reports
headache15 reports
off label use13 reports
rash12 reports
pyrexia11 reports
diarrhoea10 reports
drug hypersensitivity10 reports
pathogen resistance10 reports
drug reaction with eosinophilia and systemic symptoms9 reports
drug resistance9 reports
Frequently Asked Questions
What is Griseofulvin used for?
Griseofulvin contains Griseofulvin. It is a suspension taken oral. Consult your doctor for specific uses.
Is Griseofulvin a controlled substance?
Griseofulvin is not classified as a controlled substance by the DEA.
What is the generic name for Griseofulvin?
The generic name for Griseofulvin is Griseofulvin. There are 6 other brand versions of Griseofulvin.
What is the NDC code for Griseofulvin 125 mg/5mL?
The NDC (National Drug Code) for Griseofulvin 125 mg/5mL is 0472-0013, listed by Actavis Pharma, Inc..